首页 | 本学科首页   官方微博 | 高级检索  
检索        

武汉市359例耐多药肺结核患者治疗效果分析
引用本文:周美兰,符志军,张和武,邱鸣,陆兰英,王坚杰,陈聪,陈梓,焦新光.武汉市359例耐多药肺结核患者治疗效果分析[J].中国热带医学,2017(3):248-252.
作者姓名:周美兰  符志军  张和武  邱鸣  陆兰英  王坚杰  陈聪  陈梓  焦新光
作者单位:1. 武汉市结核病防治所,武汉市肺科医院,湖北武汉430030;2. 武汉市医疗救治中心,湖北武汉,430023
基金项目:中国全球基金结核病控制项目(CHN-S10-G14-T),武汉市卫生和计划生育委员会医疗卫生科研项目(WG15A04)
摘    要:目的分析武汉市耐多药肺结核(multi-drug resistance tuberculosis,MDR-TB)治疗效果,为进一步开展耐多药肺结核防治提供参考。方法对2006年12月1日—2014年6月30日武汉市结核病防治所治疗的全球基金结核病项目359例MDR-TB患者,采用标准化与个体化方案相结合的方式进行治疗,分析治疗转归及不良反应发生情况。结果 359例MDR-TB患者治愈率为73.3%(263/359),初治涂阳和复治涂阳患者治愈率分别为76.6%(95/124)和71.5%(168/235),复治涂阳患者中的复治失败者的治愈率最低(57.9%,22/38)。359例MDR-TB患者不良反应发生率为87.7%(315/359),耳鸣或听力下降、胃肠道反应和关节肿痛发生率分别为50.8%(160/315)、46.0%(145/315)和43.2%(136/315);环丝氨酸导致抑郁症状发生率为5.3%(6/113)。不良反应发生的时间多为治疗后的2~6个月。结论武汉市MDR-TB治愈率较高,其中全程免费政策、合理治疗方案、规范化管理及患者社会支持和人文关怀策略是关键措施。

关 键 词:结核    耐多药  治疗  武汉市

Therapeutic effect of 359 cases of multi-drug resistant pulmonary tuberculosis in Wuhan
ZHOU Melan,FU Zhijun,ZHANG Hewu,QIU Ming,LU Lanying,WANG Jianjie,CHEN Cong,CHEN Zi,JIAO Xinguang.Therapeutic effect of 359 cases of multi-drug resistant pulmonary tuberculosis in Wuhan[J].China Tropical Medicine,2017(3):248-252.
Authors:ZHOU Melan  FU Zhijun  ZHANG Hewu  QIU Ming  LU Lanying  WANG Jianjie  CHEN Cong  CHEN Zi  JIAO Xinguang
Abstract:Objective To explore the therapeutic effect of multi-drug resistant pulmonary tuberculosis (MDR-TB) in Wuhan City,so as to provide the reference for further development of MDR-TB control and prevention.Methods From December lth,2006 to June 30th,2014,359 MDR-TB patients from the Global Funds' MDR-TB Program in Wuhan City received the standardized anti-MDR-TB chemotherapy regimen supplemented with individualized drug choices.The treatment outcomes and adverse reactions were observed and the results were analyzed.Results Among the 359 MDR-TB patients,the cure rate was 73.3% (263/359),of which,the cure rates of the new smear positive and relapsed TB cases who turned out to be MDR-TB,were 76.6% (95/124) and 71.5% (168/235) respectively,and the MDR-TB patients who registered under the classification of retreatment failure had the lowest cure rate of 57.9% (22/38).The overall incidence of adverse reaction was 87.7% (315/359),and the incidence rates of tinnitus or hearing loss,gastronomical reactions and joint pain were 50.8% (160/ 315),46.0% (145/315) and 43.2% (136/315) respectively.The incidence of cycloserine inducing depression was 5.3% (6/113).The adverse reactions occurred mostly during the period of the 2nd month to 6th month after the treatment.Conclusion The cure rate of cases of MDR-TB is relatively high in Wuhan City,in which the entire free policy,reasonable treatment,standardization management,social support,and humanistic care are the key measures.
Keywords:tuberculosis  pulmonary  multidrug-resistant  treatment outcome  Wuhan City
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号